404

Not Found

Is this what you were looking for?

University 20of 20Washington 20lib modules linktrack php
By Lloyd Dunlap

Taking the fifth

PDUFA legislation is reauthorized by House and Senate for fifth time since 1992
By Lloyd Dunlap

Mayo yes, Myriad maybe

Supreme Court agrees with Mayo’s stance on Prometheus patent claims; sends Myriad Genetics case back to the Federal Circuit
By Jeffrey Bouley

Ariadne’s thread of connections

Bioinformatics company to collaborate in multimillion-dollar EU-based neuromuscular disease consortium to find biomarkers
By Arthur J. Hiller, SciFluor

Finding the right balance

If you’ve ever met with a financial planner or investment advisor, then you know that one of the first rules of investing is diversification, an important risk management technique that ensures there are a variety of assets within a portfolio. As biopharmaceutical organizations, it is important that we recognize the dire consequences that may result if we ignore this proven strategy.
By Amy Swinderman

Stem cell research: Sorting fact from fiction

For the stem cell research arena, the main source of public confusion and debate centers on the use of cell lines derived from human embryos. While society has yet to reach consensus on the ethical and moral dilemmas presented by hESC research, it’s important to remember that it’s not the only form of stem cell research.

Run a Search

March 2024 Issue Front Cover

Latest Issue  

• Volume 20 • Issue 2 • March 2024

March 2024

March 2024 Issue